Skip to content
Riskpilot
← Back to search
Sign in
Get full access
UNIPHARMA ApS
APS
Bankrupt
Advertising protection
CVR 78881917
Nygade 6, 1164
København K
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1985 · 40 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
UNIPHARMA ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Revenue
-5
—
0
0
0
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-5
0
0
0
0
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-5
0
0
0
0
Net financials
0
-5
-0
0
0
Profit before tax
-5
-5
-0
0
0
Tax
-0
-0
-0
-0
-0
Net profit
-5
-5
-0
0
0
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
180
180
181
0
0
Equity
62
57
56
-124
-124
Long-term debt
0
0
0
0
0
Short-term debt
119
124
124
124
124
Total debt
119
124
124
124
124
Financial ratios
5-year trend
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
2020
2024
Equity ratio
-12403300.0%
This company
38.2%
Market median
-32469472% vs market
2020
2024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
2020
2024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on UNIPHARMA ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
